References
- Dores GM, Matsuno RK, Weisenburger DD, et al. Hairy cell leukaemia: a heterogeneous disease? Br J Haematol. 2008;142:45–51.
- Chandana SR, Kotecha R, Al-Janadi A, et al. Rare case of hairy cell leukemia with brain parenchymal involvement: a diagnostic dilemma. J Clin Oncol. 2013;31:e186–e188.
- Knecht H, Budmiger H, Groscurth P, et al. Central nervous system involvement in hairy cell leukemia. Klin Wochenschr. 1985;63:423–427.
- Le Bezu M, Pinaudeau Y, Poirier J, et al. Involvement of the nervous system in hairy-cell leukemia. Arch Neurol. 1986;43:432.
- Kimmel DW, Hermann RC Jr, O’Neill BP. Neurologic complications of hairy cell leukemia. Arch Neurol. 1984;41:202–203.
- Wolfe DW, Scopelliti JA, Boselli BD. Leukemic meningitis in a patient with hairy cell leukemia. A case report. Cancer. 1984;54:1085–1087.
- Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364:2305–2315.
- Ascierto PA, Kirkwood JM, Grob JJ, et al. The role of BRAF V600 mutation in melanoma. J Transl Med. 2012;10:85
- Elisei R, Ugolini C, Viola D, et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab. 2008;93:3943–3949.
- Li WQ, Kawakami K, Ruszkiewicz A, et al. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer. 2006;5:2.
- Badalian-Very G, Vergilio JA, Degar BA, et al. Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol. 2012;156:163–172.
- Bailleux C, Robert G, Ginet C, et al. Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib. Oncoscience. 2015;2:44–49.
- Peyrade F, Re D, Ginet C, et al. Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation. Haematologica. 2013;98:e20–e22.
- Jain P, Polliack A, Ravandi F. Novel therapeutic options for relapsed hairy cell leukemia. Leuk Lymphoma. 2015;2:2264–2272.
- Kolar GR, Miller-Thomas MM, Schmidt RE, et al. Neoadjuvant treatment of a solitary melanoma brain metastasis with vemurafenib. J Clin Oncol. 2013;31:e40–e43.
- Kearns CM, Blakley RL, Santana VM, et al. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia. Cancer Res. 1994;54:1235–1239.